Maura Brioschi

Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.

Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure.

Proteome of endothelial cell-derived procoagulant microparticles.

Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts.

Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment.

Analysis of rosuvatatin by imaging mass spectrometry.

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.

On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients.

Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients.

Oxidized proteins in plasma of patients with heart failure: role in endothelial damage.

S 35171 exerts protective effects in spontaneously hypertensive stroke-prone rats by preserving mitochondrial function.

Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.

Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.

An integrated approach for experimental target identification of hypoxia-induced miR-210.

Proteome of platelets in patients with coronary artery disease.

Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin.

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.

Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.

Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.

Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors.

Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project.

[Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].

A mass spectrometry-based workflow for the proteomic analysis of in vitro cultured cell subsets isolated by means of laser capture microdissection.

Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control.

Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor.

Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure. A pilot single-center prospective study.

BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.

Corrigendum to "Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor" [Data Brief 3 (2015) 117-119].

A preliminary study on human placental tissue impaired by gestational diabetes: a comparison of gel-based versus gel-free proteomics approaches.

Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.

Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.